1 / 32

Permissive hypoxaemia – key issues

Permissive hypoxaemia – key issues. How much oxygen do you need? “natural experiments” “critical care research” Is oxygen toxic?. Origins of mitochondria – ancient invasions > 1.5 billion years ago. -proteobacterium. Eukaryote. proto-mitochondria. gene transfer.

tova
Télécharger la présentation

Permissive hypoxaemia – key issues

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Permissive hypoxaemia – key issues • How much oxygen do you need? • “natural experiments” • “critical care research” • Is oxygen toxic?

  2. Origins of mitochondria – ancient invasions > 1.5 billion years ago -proteobacterium Eukaryote proto-mitochondria gene transfer • genetic similarity to bacteria • What drove the union • protect anarobic host from oxygen tension

  3. Energy production in Mitochondria mitochondria glucose pyruvate O2 Pyruvate +O2 H2O & CO2 pyruvate + O2 2 ATP 30 ATP glycolysis Oxidative phosphorylation Inefficient process Very efficient process

  4. Energy production in Mitochondria Outer membrane Inner membrane H+ H+ H+ O2 e 2H2O H+ ADP ATP matrix

  5. Ascent without oxygen All 8000+ m peaks have been climbed without O2

  6. Altitudes

  7. What is the alveolar PO2 at altitude? Alveolar PO2 PIO2 -PaCO2 Everest summit PAO2 = 5.0 -5.0 = 0!!

  8. What is the alveolar PCO2 at altitude? PACO2 CO2 output/alveolar ventilation

  9. Gas transfer at altitude Diffusion limited PaO2 3.5 kPa

  10. What is the arterial oxygen content at altitude?

  11. Oxygen delivery at altitude VO2 = cardiac output X arterial O2 content

  12. Supplemental oxygen and montaineer death rates on Everest and K2 - JAMA 2000

  13. How high can you go? • Two theories of the “vertical limit” • Oxygen delivery limit • Oxygen diffusion limit from capillary to mitochondria

  14. Adaptation to prolonged hypoxaemia • Cardiac output • Respiratory rate and MV • Haemoglobin • Skeletal muscle • ? Capillary/endothelial • ? Mitochondrial/OXPHOS

  15. Hypoxaemia & Metabolism Hypoxia Inducible factor Transduction factor > 100 genes Erythropoietin Metabolism Angiogenesis Cell differentiation

  16. Genetics & hypoxia Climbers Success

  17. Oxygen toxicity • Oxygen is bad for you! • Oxidative phosphorylation vs. ROS • Ubiquitous cellular defences against ROS • Marked depletion of these in critically ill • Many trials of “anti-oxidants” • No RCTs of limiting oxygen

  18. (Crit Care Med 2004; 32:2496 –2501)

  19. Additive effects of high TV and high oxygen Inflammatory cells permeability cytokines

  20. Oxygen toxicity in adult man • FIO2 75 – 100% • Tracheobronchitis • Loss of VC • Time & dose dependent • Single volunteer FIO2 100% for 100 hrs • Deteriorating respiratory function • Acute respiratory failure • Winter PA Anaesthesiology 1972;37:210

  21. O2 toxicity in healthy man

  22. O2 toxicity in adult ventilated patients • “Irreversible coma” • 100% O2 for a few days • Patchy pulmonary infiltrates & reduced gas exchange • Barber New Engl J Med 1970; 283:1478-84 • Five patients with neuromuscular disease • 85-100 % FIO2 for a few days • Patch chest radiology changes • Fever • Raised wbc • No infection • Hyde Ann Intern Med 1969;71;517-31

  23. High v lower PEEP in patients with ARDSNEJM 2004

  24. Permissive hypoxaemia in prolonged Mechanical Ventilation • Experimental evidence for O2 toxicity in the lung • Evidence for additive effect of hyperoxia on VILI • No evidence that survival is determined by oxygenation alone

  25. Hypothesis • Ventilation at a reduced FIO2 (accepting lower SaO2) will improve outcome in patients receiving prolonged (4+ day mechanical ventilation) in General ITUs

  26. Conclusions • We do not know how low we can allow oxygen delivery to fall • Our patients are not Mountaineers! • Increase CO • Increase RR • Increase Hb • Adapt by complex changes in gene expression • Good genes

  27. Conclusions • Oxygen toxicity occurs in small animals and neonates • Some but controversial evidence in healthy man • Little or no evidence in the critically ill • Shouldn't assume that oxygen is harmless (= a drug at FIO2 > 21%) • Need for more research

More Related